Naringin ameliorates memory deficits and exerts neuroprotective effects in a mouse model of Alzheimer's disease by regulating multiple metabolic pathways

Meng,Xiangdong; Fu,Mingming; Wang,Shoufeng; Chen,Weida; Wang,Jianjie; Zhang,Ning

doi:10.3892/mmr.2021.11971

Naringin ameliorates memory deficits and exerts neuroprotective effects in a mouse model of Alzheimer's disease by regulating multiple metabolic pathways

Authors:
- Xiangdong Meng
- Mingming Fu
- Shoufeng Wang
- Weida Chen
- Jianjie Wang
- Ning Zhang
View Affiliations

Affiliations: Nanchong Central Hospital, Second Clinical Medical College, Nanchong, Sichuan 637000, P.R. China, Foreign Language Department, North Sichuan Medical College (University), Nanchong, Sichuan 637000, P.R. China, Affiliated First Hospital, Jiamusi University, Jiamusi, Heilongjiang 154002, P.R. China, College of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154002, P.R. China, Jiamusi College, College of Pharmacy, Heilongjiang University of Chinese Medicine, Jiamusi, Heilongjiang 154007, P.R. China
Published online on: March 8, 2021 https://doi.org/10.3892/mmr.2021.11971
Article Number: 332
Copyright: © Meng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the neuroprotective effects of naringin on the memory impairment of hydrocortisone mice, and to elucidate the potential underlying molecular mechanisms. In the present study, a hydrocortisone model was constructed. Novel object recognition, Morris water maze and step‑down tests were performed in order to assess the learning and memory abilities of mice. Hematoxylin and eosin staining was used to observe pathological changes in the hippocampus and hypothalamus. Transmission electron microscopy was used to observe the ultrastructural changes in the hippocampus. Immunohistochemistry was used to detect the expression of ERα and ERβ. Western blotting was performed to detect the expression of each protein in the relevant system. It was found that naringin can significantly improve cognitive, learning and memory dysfunction in mice with hydrocortisone memory impairment. In addition, naringin can exert neuroprotective effects through a variety of mechanisms, including amyloid β metabolism, Tau protein hyperphosphorylation, acetylcholinergic system, glutamate receptor system, oxidative stress and cell apoptosis. Naringin can also affect the expression of phosphorylated‑P38/P38, indicating that the neuroprotective effect of naringin may also involve the MAPK/P38 pathway. The results of the present study concluded that naringin can effectively improve the cognitive abilities of mice with memory impairment and exert neuroprotective effects. Thus, naringin may be a promising target drug candidate for the treatment of Alzheimer's disease.

View Figures

View References

1	Sachdeva AK, Kuhad A and Chopra K: Naringin ameliorates memory deficits in experimental paradigm of Alzheimer's disease by attenuating mitochondrial dysfunction. Pharmacol Biochem Behav. 127:101–110. 2014. View Article : Google Scholar : PubMed/NCBI
2	Ballatore C, Lee VM and Trojanowski JQ: Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci. 8:663–672. 2007. View Article : Google Scholar : PubMed/NCBI
3	Auld DS, Kornecook TJ, Bastianetto S and Quirion R: Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol. 68:209–245. 2002. View Article : Google Scholar : PubMed/NCBI
4	Honjo H, Iwasa K, Kawata M, Fushiki S, Hosoda T, Tatsumi H, Oida N, Mihara M, Hirasugi Y, Yamamoto H, et al: Progestins and estrogens and Alzheimer's disease. J Steroid Biochem Mol Biol. 93:305–308. 2005. View Article : Google Scholar : PubMed/NCBI
5	Gao Y, Li C, Yin J, Shen J, Wang H, Wu Y and Jin H: Fucoidan, a sulfated polysaccharide from brown algae, improves cognitive impairment induced by infusion of Aβ peptide in rats. Environ Toxicol Pharmacol. 33:304–311. 2012. View Article : Google Scholar : PubMed/NCBI
6	Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H and Trojanowski JQ: Total and phosphorylated tau protein as biological markers of Alzheimer's disease. Exp Gerontol. 45:30–40. 2010. View Article : Google Scholar : PubMed/NCBI
7	Ferreira-Vieira TH, Guimaraes IM, Silva FR and Ribeiro FM: Alzheimer's disease: Targeting the cholinergic system. Curr Neuropharmacol. 14:101–115. 2016. View Article : Google Scholar : PubMed/NCBI
8	Medina M: Recent developments in tau-based therapeutics for neurodegenerative diseases. Recent Pat CNS Drug Discov. 6:20–30. 2011. View Article : Google Scholar : PubMed/NCBI
9	He LY, He XH, Pang GF, Liang QH, Yang Z and Hu CY: The pathogenesis and treatment of Alzheimer's disease. Chin Geriatric Care Med. 15:12–14. 2017.(In Chinese).
10	Chen L and DiWu YC: Research progress on the relationship between hippocampal nerve cell senescence and neurogenesis and Alzheimer's disease. Hebei J Tradit Chin Med. 39:1583–1587. 2017.(In Chinese).
11	Guzior N, Wieckowska A, Panek D and Malawska B: Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease. Curr Med Chem. 22:373–404. 2015. View Article : Google Scholar : PubMed/NCBI
12	Xu ZL, Xu MY, Wang HT, Xu QX, Liu MY, Jia CP, Geng F and Zhang N: Pharmacokinetics of eight flavonoids in rats assayed by UPLC-MS/MS after oral administration of Drynariae rhizoma extract. J Anal Methods Chem. 2018:47891962018. View Article : Google Scholar : PubMed/NCBI
13	Yang Z, Kuboyama T and Tohda C: A Systematic strategy for discovering a therapeutic drug for Alzheimer's disease and its target molecule. Front Pharmacol. 8:3402017. View Article : Google Scholar : PubMed/NCBI
14	Chen R, Qi QL, Wang MT and Li QY: Therapeutic potential of naringin: An overview. Pharm Biol. 54:3203–3210. 2016. View Article : Google Scholar : PubMed/NCBI
15	Golechha M, Sarangal V, Bhatia J, Chaudhry U, Saluja D and Arya DS: Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: Possible mechanisms of neuroprotection. Epilepsy Behav. 41:98–102. 2014. View Article : Google Scholar : PubMed/NCBI
16	Golechha M, Chaudhry U, Bhatia J, Saluja D and Arya DS: Naringin protects against kainic acid-induced status epilepticus in rats: Evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol Pharm Bull. 34:360–365. 2011. View Article : Google Scholar : PubMed/NCBI
17	Kumar P and Kumar A: Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: Possible role of nitric oxide. Behav Brain Res. 206:38–46. 2010. View Article : Google Scholar : PubMed/NCBI
18	Cao W, Feng SJ and Kan MC: Naringin targets NFKB1 to alleviate oxygen-glucose deprivation/reoxygenation-induced injury in PC12 cells via modulating HIF-1α/AKT/mTOR-signaling pathway. J Mol Neurosci. 71:101–111. 2021. View Article : Google Scholar : PubMed/NCBI
19	Wang DM, Yang YJ, Zhang L, Zhang X, Guan FF and Zhang LF: Naringin enhances CaMKII activity and improves long-term memory in a mouse model of Alzheimer's disease. Int J Mol Sci. 14:5576–5586. 2013. View Article : Google Scholar : PubMed/NCBI
20	Li C, Wang H and Wang L: Replication of a rat model of renal insufficiency Alzheimer's disease. J Anhui Coll Tradit Chin Med. 32:62–67. 2013.(In Chinese).
21	Mathiasen JR and DiCamillo A: Novel object recognition in the rat: A facile assay for cognitive function. Curr Protoc Pharmacol Chapter. 5:Unit 5.59. 2010.
22	Gao Y, Yin H, Zhang Y, Dong Y, Yang F, Wu X and Liu H: Dexmedetomidine protects hippocampal neurons against hypoxia/reoxygenation-induced apoptosis through activation HIF-1α/p53 signaling. Life Sci. 232:1166112019. View Article : Google Scholar : PubMed/NCBI
23	Bolt D, Giger R, Wirth S and Swanenburg J: Step-down test assessment of postural stability in patients with chronic ankle instability. J Sport Rehabil. 27:2018. View Article : Google Scholar : PubMed/NCBI
24	Kimura A, Hata S and Suzuki T: Alternative selection of β-site APP-cleaving enzyme 1 (BACE1) cleavage sites in amyloid β-protein precursor (APP) harboring protective and pathogenic mutations within the Aβ sequence. J Biol Chem. 291:24041–24053. 2016. View Article : Google Scholar : PubMed/NCBI
25	Holtzman DM, Morris JC and Goate AM: Alzheimer's disease: The challenge of the second century. Sci Transl Med. 3:77sr12011. View Article : Google Scholar : PubMed/NCBI
26	Ali MY, Jannat S, Edraki N, Das S, Chang WK, Kim HC, Park SK and Chang MS: Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway. Chem Biol Interact. 309:1087072019. View Article : Google Scholar : PubMed/NCBI
27	Lopes S, Lopes A, Pinto V, Guimarães MR, Sardinha VM, Duarte-Silva S, Pinheiro S, Pizarro J, Oliveira JF, Sousa N, et al: Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment. Aging Cell. 15:208–216. 2016. View Article : Google Scholar : PubMed/NCBI
28	Saito T, Oba T, Shimizu S, Asada A, Iijima KM and Ando K: Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262. Hum Mol Genet. 28:3062–3071. 2019. View Article : Google Scholar : PubMed/NCBI
29	Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, et al: Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin. J Neurosci. 29:9078–9089. 2009. View Article : Google Scholar : PubMed/NCBI
30	Fan S, Xian X, Li L, Yao X, Hu Y, Zhang M and Li W: Ceftriaxone improves cognitive function and upregulates GLT-1-related glutamate-glutamine cycle in APP/PS1 mice. J Alzheimers Dis. 66:1731–1743. 2018. View Article : Google Scholar : PubMed/NCBI
31	Ashpole NM and Hudmon A: Excitotoxic neuroprotection and vulnerability with CaMKII inhibition. Mol Cell Neurosci. 46:720–730. 2011. View Article : Google Scholar : PubMed/NCBI
32	Pellegrini-Giampietro DE, Gorter JA, Bennett MV and Zukin RS: The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20:464–470. 1997. View Article : Google Scholar : PubMed/NCBI
33	Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC and Nicoletti F: Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J Neurosci. 24:6021–6027. 2004. View Article : Google Scholar : PubMed/NCBI
34	Jarskog LF, Selinger ES, Lieberman JA and Gilmore JH: Apoptotic proteins in the temporal cortex in schizophrenia: High Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry. 161:109–115. 2004. View Article : Google Scholar : PubMed/NCBI
35	Lok J and Martin LJ: Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J Neurotrauma. 19:815–825. 2002. View Article : Google Scholar : PubMed/NCBI
36	Gu Y, Chen X, Shang C, Singh K, Barzegar M, Mahdavian E, Salvatore BA, Jiang S and Huang S: Fusarochromanone induces G1 cell cycle arrest and apoptosis in COS7 and HEK293 cells. PLoS One. 11:e1126412014. View Article : Google Scholar
37	Goodenough S, Schäfer M and Behl C: Estrogen-induced cell signalling in a cellular model of Alzheimer's disease. J Steroid Biochem Mol Biol. 84:301–305. 2003. View Article : Google Scholar : PubMed/NCBI
38	Wang H, Muiznieks LD, Ghosh P, Williams D, Solarski M, Fang A, Ruiz-Riquelme A, Pomès R, Watts JC, Chakrabartty A, et al: Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers. Elife. 6:e284012017. View Article : Google Scholar : PubMed/NCBI
39	Torres-Cuevas I, Parra-Llorca A, Sánchez-Illana A, Nuñez-Ramiro A, Kuligowski J, Cháfer-Pericás C, Cernada M, Escobar J and Vento M: Oxygen and oxidative stress in the perinatal period. Redox Biol. 12:674–681. 2017. View Article : Google Scholar : PubMed/NCBI
40	Amin MM, Rafiei N, Poursafa P, Ebrahimpour K, Mozafarian N, Shoshtari-Yeganeh B, Hashemi M and Kelishadi R: Association of benzene exposure with insulin resistance, SOD, and MDA as markers of oxidative stress in children and adolescents. Environ Sci Pollut Res Int. 25:34046–34052. 2018. View Article : Google Scholar : PubMed/NCBI
41	Wang Z, Yu J, Wu J, Qi F, Wang H, Wang Z and Xu Z: Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress. Life Sci. 157:200–207. 2016. View Article : Google Scholar : PubMed/NCBI
42	Wang YX, Tian K, He CC, Ma XL, Zhang F, Wang HG, An D, Heng B, Jiang YG and Liu YQ: Genistein inhibits hypoxia, ischemic-induced death, and apoptosis in PC12 cells. Environ Toxicol Pharmacol. 50:227–233. 2017. View Article : Google Scholar : PubMed/NCBI
43	Xu XF, Liu F, Xin JQ, Fan JW, Wu N, Zhu LJ, Duan LF, Li YY and Zhang H: Respective roles of the mitogen-activated protein kinase (MAPK) family members in pancreatic stellate cell activation induced by transforming growth factor-β1 (TGF-β1). Biochem Biophys Res Commun. 501:365–373. 2018. View Article : Google Scholar : PubMed/NCBI
44	Sui X, Kong N, Ye L, Han W, Zhou J, Zhang Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 344:174–179. 2014. View Article : Google Scholar : PubMed/NCBI